Analystreport

Coherus BioSciences (NASDAQ: CHRS) was given a new $18.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock.

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com